NCT05017662Completed
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
A Multicentre Surveillance Study to Evaluate the Long-term Safety in Participants Who Have Been Previously Treated With 177Lu-IPN01072 in an Ipsen-sponsored Clinical Study
Source: ClinicalTrials.gov · Last updated 4 Sept 2025
Brief summary (registry, in English)
The purpose of the protocol is to evaluate the long-term safety of medicine 177Lu-satoreotide tetraxetan (also known as 177Lu-IPN01072 or 177Lu-OPS201) for patients who have previously received 177Lu-satoreotide tetraxetan in the clinical study OPS-C-001 / D-FR-01072-001.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 6 Aug 2021
- Start date
- 14 Sept 2021
- Primary completion date
- 29 Apr 2025
- Lead sponsor
- Ariceum Therapeutics GmbH
- Diseases
- Neuroendocrine tumours
- NCT number
- NCT05017662
- EU CT number
- 2024-515071-35-00
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 14 Sept 2021 to the primary completion date, 29 Apr 2025
- 7 sites in 6 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- There are no exclusion criteria in this safety surveillance study.
Who the study is looking for
- Participant is capable of giving signed informed consent
- Participant must have received at least one infusion of 177Lu-IPN01072 in Study OPS-C-001
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Vienna Coordinator of this site? Confirm its status | Vienna | Austria | Unknown status |
| Peter MacCallum Cancer Center Coordinator of this site? Confirm its status | Melbourne | Australia | Unknown status |
| Ramsay Hollywood Private Hospital Coordinator of this site? Confirm its status | Perth | Australia | Unknown status |
| University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
| Hôtel Dieu de Nantes Coordinator of this site? Confirm its status | Nantes | France | Unknown status |
| Royal Free Hospital London Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.